News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Positive Results Presented From Phase 2 Clinical Trial Of Biothera's Imprime PGG Cancer Immunotherapy In Non-Small Lung Cancer Patients



1/8/2014 9:33:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EAGAN, Minn.--(BUSINESS WIRE)--Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Biothera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES